首页 > 最新文献

Annals of Gastroenterological Surgery最新文献

英文 中文
Evaluation of the advantage of surgeons certified by the endoscopic surgical skill qualification system participating in laparoscopic low anterior rectal resection 评估经内窥镜手术技能资格认证系统认证的外科医生参与腹腔镜低位直肠前切除术的优势
IF 2.7 4区 医学 Q1 Medicine Pub Date : 2023-12-14 DOI: 10.1002/ags3.12763
Naruhiko Sawada, Tomonori Akagi, Manabu Shimomura, Yukitoshi Todate, Kunihiko Nagakari, Hiroaki Takeshita, Satoshi Maruyama, Manabu Takata, Nobuki Ichikawa, Koya Hida, Hiroaki Iijima, Shigeki Yamaguchi, Akinobu Taketomi, Takeshi Naitoh, The EnSSURE Study Group Collaboratives in Japan Society of Laparoscopic Colorectal Surgery.

Background

A technical qualification system was developed in 2004 by the Japan Society for Endoscopic Surgery. An analysis of the EnSSURE study on 3188 stage II–III rectal cancer patients, which was performed by including the participation of qualified surgeons as assistants and advisers without restricting their participation as operators, revealed that the participation of technically qualified surgeons in surgery improved the technical and oncological safety of laparoscopic rectal resection.

Aim

This secondary retrospective analysis of the EnSSURE study examined the advantage of qualified surgeons participating in laparoscopic low anterior resection (LAR).

Methods

The outcomes of low anterior resection were compared between groups with and without the participation of surgeons qualified by the Endoscopic Surgical Skill Qualification System (Q and non-Q groups, respectively). We used propensity score matching to generate paired cohorts at a one-to-one ratio. The postoperative complication rate, short-term results (hemorrhage volume, operative time, number of dissected lymph nodes, open conversion rate, intraoperative complication rate, and R0 resection rate), and long-term results (disease-free survival rate, local recurrence rate, and overall survival rate) were evaluated.

Results

The frequencies of postoperative complications, anastomotic bleeding, and intraperitoneal abscess were significantly lower, the operative time was significantly shorter, the postoperative hospital stay was significantly shorter, and the number of dissected lymph nodes was higher in the Q group. No significant differences were observed in disease-free survival, local recurrence, or overall survival rate rates between the groups.

Conclusion

The participation of qualified surgeons in LAR is technically advantageous.

日本内窥镜外科协会于 2004 年制定了一套技术资格制度。对 3188 名 II-III 期直肠癌患者进行的 EnSSURE 研究分析表明,技术合格的外科医生参与手术提高了腹腔镜直肠切除术的技术和肿瘤安全性。这项对 EnSSURE 研究的二次回顾性分析探讨了合格外科医生参与腹腔镜低位前路切除术(LAR)的优势。我们比较了有内镜手术技能资格系统合格外科医生参与和没有内镜手术技能资格系统合格外科医生参与的两组(分别为 Q 组和非 Q 组)低位前路切除术的结果。我们采用倾向得分匹配法,以一对一的比例生成配对队列。我们对术后并发症发生率、短期疗效(出血量、手术时间、切除淋巴结数量、开放转化率、术中并发症发生率和 R0 切除率)和长期疗效(无病生存率、局部复发率和总生存率)进行了评估。Q组术后并发症、吻合口出血和腹腔内脓肿的发生率明显降低,手术时间明显缩短,术后住院时间明显缩短,切除淋巴结的数量较多。两组的无病生存率、局部复发率和总生存率无明显差异。
{"title":"Evaluation of the advantage of surgeons certified by the endoscopic surgical skill qualification system participating in laparoscopic low anterior rectal resection","authors":"Naruhiko Sawada,&nbsp;Tomonori Akagi,&nbsp;Manabu Shimomura,&nbsp;Yukitoshi Todate,&nbsp;Kunihiko Nagakari,&nbsp;Hiroaki Takeshita,&nbsp;Satoshi Maruyama,&nbsp;Manabu Takata,&nbsp;Nobuki Ichikawa,&nbsp;Koya Hida,&nbsp;Hiroaki Iijima,&nbsp;Shigeki Yamaguchi,&nbsp;Akinobu Taketomi,&nbsp;Takeshi Naitoh,&nbsp;The EnSSURE Study Group Collaboratives in Japan Society of Laparoscopic Colorectal Surgery.","doi":"10.1002/ags3.12763","DOIUrl":"10.1002/ags3.12763","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>A technical qualification system was developed in 2004 by the Japan Society for Endoscopic Surgery. An analysis of the EnSSURE study on 3188 stage II–III rectal cancer patients, which was performed by including the participation of qualified surgeons as assistants and advisers without restricting their participation as operators, revealed that the participation of technically qualified surgeons in surgery improved the technical and oncological safety of laparoscopic rectal resection.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>This secondary retrospective analysis of the EnSSURE study examined the advantage of qualified surgeons participating in laparoscopic low anterior resection (LAR).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>The outcomes of low anterior resection were compared between groups with and without the participation of surgeons qualified by the Endoscopic Surgical Skill Qualification System (<i>Q</i> and non-<i>Q</i> groups, respectively). We used propensity score matching to generate paired cohorts at a one-to-one ratio. The postoperative complication rate, short-term results (hemorrhage volume, operative time, number of dissected lymph nodes, open conversion rate, intraoperative complication rate, and R0 resection rate), and long-term results (disease-free survival rate, local recurrence rate, and overall survival rate) were evaluated.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The frequencies of postoperative complications, anastomotic bleeding, and intraperitoneal abscess were significantly lower, the operative time was significantly shorter, the postoperative hospital stay was significantly shorter, and the number of dissected lymph nodes was higher in the <i>Q</i> group. No significant differences were observed in disease-free survival, local recurrence, or overall survival rate rates between the groups.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>The participation of qualified surgeons in LAR is technically advantageous.</p>\u0000 </section>\u0000 </div>","PeriodicalId":8030,"journal":{"name":"Annals of Gastroenterological Surgery","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2023-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ags3.12763","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138971594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adequate gross resection margin length ensuring pathologically complete resection in gastrectomy for gastric cancer: A systematic review and meta-analysis 胃癌胃切除术中确保病理完全切除的足够总切除缘长度:系统回顾和荟萃分析
IF 2.7 4区 医学 Q1 Medicine Pub Date : 2023-12-05 DOI: 10.1002/ags3.12761
Masaru Hayami, Manabu Ohashi, Nozomi Kurihara, Souya Nunobe

Aim

A positive resection margin (RM) is associated with poor survival after gastrectomy for gastric cancer (GC). However, the adequate RM length to avoid a positive RM remains controversial. We performed a systematic review to examine the RM length required to avoid a positive RM in gastrectomy for GC.

Methods

This systematic review involved all relevant articles identified in PubMed, the Cochrane Library, Web of Science, and ClinicalTrials.gov until August 2023. The incidence of a positive RM related to the RM length and the possible incidence of a positive RM estimated from the discrepancy between the gross and pathological RM length were evaluated. The Newcastle–Ottawa Scale was used to quantify study quality.

Results

Thirteen studies involving 8983 patients were analyzed. Investigation of the incidence of a positive RM in relation to the RM length showed that a proximal RM length of 6 cm guaranteed a negative RM in gastrectomy. Analyses of the possible incidence of a positive RM revealed that a negative RM would be guaranteed if the proximal RM length was 6 cm in distal gastrectomy, if the esophageal resection length was 2 cm in total gastrectomy for GC without esophageal invasion and 2.5 cm in total or proximal gastrectomy for GC with esophageal invasion or esophagogastric junction cancer, and if the distal RM length was 4 cm in proximal gastrectomy for early GC.

Conclusions

The adequate RM lengths to ensure a pathologically negative RM in each type of gastrectomy for GC were herein suggested.

胃癌(GC)胃切除术后,切缘阳性(RM)与生存率低相关。然而,足够的RM长度以避免正RM仍然存在争议。我们进行了一项系统的综述,以检查胃癌切除术中避免RM阳性所需的RM长度。该系统综述包括截至2023年8月在PubMed、Cochrane图书馆、Web of Science和ClinicalTrials.gov中发现的所有相关文章。评估与RM长度相关的阳性RM的发生率,以及从大体RM长度和病理RM长度之间的差异估计的阳性RM的可能发生率。纽卡斯尔-渥太华量表用于量化研究质量。13项研究涉及8983例患者进行了分析。对RM阳性的发生率与RM长度的关系的研究表明,近端RM长度为6cm保证了胃切除术中RM的阴性。对RM阳性可能发生率的分析显示,远端胃切除术中RM近端长度为6cm,未侵犯食管的胃癌全胃切除术中食管切除长度为2cm,伴食管侵犯或食管胃结癌的胃癌全胃或近端切除术中食管切除长度为2.5 cm,早期胃癌近端切除术中RM远端长度为4cm,均可保证RM阴性。适当的RM长度,以确保病理阴性RM在每一种胃切除术的胃癌在这里被建议。
{"title":"Adequate gross resection margin length ensuring pathologically complete resection in gastrectomy for gastric cancer: A systematic review and meta-analysis","authors":"Masaru Hayami,&nbsp;Manabu Ohashi,&nbsp;Nozomi Kurihara,&nbsp;Souya Nunobe","doi":"10.1002/ags3.12761","DOIUrl":"10.1002/ags3.12761","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>A positive resection margin (RM) is associated with poor survival after gastrectomy for gastric cancer (GC). However, the adequate RM length to avoid a positive RM remains controversial. We performed a systematic review to examine the RM length required to avoid a positive RM in gastrectomy for GC.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This systematic review involved all relevant articles identified in PubMed, the Cochrane Library, Web of Science, and ClinicalTrials.gov until August 2023. The incidence of a positive RM related to the RM length and the possible incidence of a positive RM estimated from the discrepancy between the gross and pathological RM length were evaluated. The Newcastle–Ottawa Scale was used to quantify study quality.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Thirteen studies involving 8983 patients were analyzed. Investigation of the incidence of a positive RM in relation to the RM length showed that a proximal RM length of 6 cm guaranteed a negative RM in gastrectomy. Analyses of the possible incidence of a positive RM revealed that a negative RM would be guaranteed if the proximal RM length was 6 cm in distal gastrectomy, if the esophageal resection length was 2 cm in total gastrectomy for GC without esophageal invasion and 2.5 cm in total or proximal gastrectomy for GC with esophageal invasion or esophagogastric junction cancer, and if the distal RM length was 4 cm in proximal gastrectomy for early GC.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>The adequate RM lengths to ensure a pathologically negative RM in each type of gastrectomy for GC were herein suggested.</p>\u0000 </section>\u0000 </div>","PeriodicalId":8030,"journal":{"name":"Annals of Gastroenterological Surgery","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2023-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ags3.12761","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138599145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How do we prevent severe intra-abdominal infectious complications following minimally invasive gastrectomy for cancer? The usefulness of a novel marker using computed tomography images (minimum umbilicus–vertebra diameter) and robotic surgery 如何预防癌症微创胃切除术后的严重腹腔内感染并发症?使用计算机断层扫描图像(脐-椎体最小直径)和机器人手术的新型标记的实用性
IF 2.7 4区 医学 Q1 Medicine Pub Date : 2023-12-03 DOI: 10.1002/ags3.12760
Naoshi Kubo, Katsunobu Sakurai, Tsuyoshi Hasegawa, Junya Nishimura, Yasuhito Iseki, Takafumi Nishii, Sadatoshi Shimizu, Toru Inoue, Yukio Nishiguchi, Kiyoshi Maeda

Background

Intra-abdominal infectious complications (IAICs) following minimally invasive gastrectomy (MIG) for cancer sometimes worsen short- and long-term outcomes. In this study, we focused on the minimum umbilicus–vertebra diameter (MUVD) in preoperative computed tomography (CT) images and robotic surgery to prevent severe IAIC occurrence.

Patients and Methods

A total of 400 patients with gastric cancer who underwent 204 laparoscopic gastrectomy (LG) and 196 robotic gastrectomy (RG) procedures were enrolled in this study. We retrospectively investigated the significance of the MUVD and robotic surgery for preventing severe IAICs following MIG using multivariate and propensity score matching analysis.

Results

The MUVD cutoff value was 84 mm by receiver operating characteristic (ROC) curve using severe IAICs as the end point. The MUVD and visceral fat area (VFA) had significantly higher area under the curve (AUC) than BMI (MUVD vs. BMI, p = 0.032; VFA vs. BMI, p < 0.01). In the multivariate analysis, high MUVD (HR, 9.46; p = 0.026) and laparoscopic surgery (HR, 3.35; p = 0.042) were independent risk factors for severe IAIC occurrence. In the propensity matching analysis between robotic and laparoscopic surgery in the high MUVD group, the RG group tended to have a lower severe IAIC rate than the LG group (0% vs. 9.8%, p = 0.056).

Conclusion

The MUVD was a novel and easy-measuring predictor of severe IAICs following MIG. Robotic surgery should be considered first in patients with gastric cancer having an MUVD value of 84 mm or higher from the perspective of severe IAIC occurrence.

微创胃切除术(MIG)治疗癌症后腹腔内感染并发症(iiac)有时会恶化短期和长期预后。在本研究中,我们重点关注术前计算机断层扫描(CT)图像中的最小脐椎体直径(MUVD)和机器人手术,以防止严重的IAIC发生。共有400名胃癌患者接受了204例腹腔镜胃切除术(LG)和196例机器人胃切除术(RG)。我们采用多变量和倾向评分匹配分析回顾性研究了MUVD和机器人手术在预防MIG后严重iiac中的意义。以重度iiac为终点的受试者工作特征(ROC)曲线MUVD截止值为84 mm。MUVD和内脏脂肪面积(VFA)的曲线下面积(AUC)明显高于BMI (MUVD vs. BMI, p = 0.032;VFA vs. BMI, p < 0.01)。多因素分析中,高MUVD (HR, 9.46;p = 0.026)和腹腔镜手术(HR, 3.35;p = 0.042)是严重IAIC发生的独立危险因素。在高MUVD组机器人和腹腔镜手术的倾向匹配分析中,RG组倾向于比LG组有更低的严重IAIC发生率(0%比9.8%,p = 0.056)。MUVD是一种新颖且易于测量的MIG后严重iiac预测指标。从IAIC发生严重的角度来看,对于MUVD值≥84 mm的胃癌患者,应优先考虑机器人手术。
{"title":"How do we prevent severe intra-abdominal infectious complications following minimally invasive gastrectomy for cancer? The usefulness of a novel marker using computed tomography images (minimum umbilicus–vertebra diameter) and robotic surgery","authors":"Naoshi Kubo,&nbsp;Katsunobu Sakurai,&nbsp;Tsuyoshi Hasegawa,&nbsp;Junya Nishimura,&nbsp;Yasuhito Iseki,&nbsp;Takafumi Nishii,&nbsp;Sadatoshi Shimizu,&nbsp;Toru Inoue,&nbsp;Yukio Nishiguchi,&nbsp;Kiyoshi Maeda","doi":"10.1002/ags3.12760","DOIUrl":"10.1002/ags3.12760","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Intra-abdominal infectious complications (IAICs) following minimally invasive gastrectomy (MIG) for cancer sometimes worsen short- and long-term outcomes. In this study, we focused on the minimum umbilicus–vertebra diameter (MUVD) in preoperative computed tomography (CT) images and robotic surgery to prevent severe IAIC occurrence.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Patients and Methods</h3>\u0000 \u0000 <p>A total of 400 patients with gastric cancer who underwent 204 laparoscopic gastrectomy (LG) and 196 robotic gastrectomy (RG) procedures were enrolled in this study. We retrospectively investigated the significance of the MUVD and robotic surgery for preventing severe IAICs following MIG using multivariate and propensity score matching analysis.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The MUVD cutoff value was 84 mm by receiver operating characteristic (ROC) curve using severe IAICs as the end point. The MUVD and visceral fat area (VFA) had significantly higher area under the curve (AUC) than BMI (MUVD vs. BMI, <i>p</i> = 0.032; VFA vs. BMI, <i>p</i> &lt; 0.01). In the multivariate analysis, high MUVD (HR, 9.46; <i>p</i> = 0.026) and laparoscopic surgery (HR, 3.35; <i>p</i> = 0.042) were independent risk factors for severe IAIC occurrence. In the propensity matching analysis between robotic and laparoscopic surgery in the high MUVD group, the RG group tended to have a lower severe IAIC rate than the LG group (0% vs. 9.8%, <i>p</i> = 0.056).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>The MUVD was a novel and easy-measuring predictor of severe IAICs following MIG. Robotic surgery should be considered first in patients with gastric cancer having an MUVD value of 84 mm or higher from the perspective of severe IAIC occurrence.</p>\u0000 </section>\u0000 </div>","PeriodicalId":8030,"journal":{"name":"Annals of Gastroenterological Surgery","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2023-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ags3.12760","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138605821","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Author's reply: COVID-19 vaccine in liver transplant recipients 作者回复:肝移植受者接种 COVID-19 疫苗
IF 2.7 4区 医学 Q1 Medicine Pub Date : 2023-11-27 DOI: 10.1002/ags3.12752
Atsuyoshi Mita, Yasunari Ohno, Yuji Soejima

We gratefully acknowledge Drs. Daungsupawong and Wiwanitkit's insights regarding our recently published article “Antibody titer after administration of mRNA-based vaccine against severe acute respiratory syndrome coronavirus 2 in liver transplant recipients.”1 We reported that mRNA vaccines induce similar humoral responses and decay rates of acquired antibodies in liver-transplant recipients as in healthy individuals.2 Accordingly, we deduced that liver-transplant recipients should receive booster vaccination. Although we agree with the majority of the authors' points, we would like to address some of their concerns that were expressed in their Letter to the Editor.

In Japan, as the local government has provided free vaccination against the coronavirus disease (COVID-19), liver-transplant recipients have good access to healthcare. Adults were eligible for vaccination throughout, and children could receive vaccination midway through, the study period. Based on the study's results, liver-transplant recipients received regular vaccinations, and continued to receive booster vaccinations (given every 6 months after the second vaccination) even after the study ended. The average observation period for target patients after the second vaccination was 328 ± 64 days in the study.

With regard to the pre-vaccination history of infections, the impact was likely small, as only two recipients tested positive for anti-nucleocapsid antibodies at the first measurement. Although, data on current infection rates are unavailable, no recipient has developed severe pneumonia in the 1 year since study completion. In the statistics reported by the Japan Society for Transplantation on COVID-19 cases up to August 31, 2022,3 only 237 recipients, including those from our facility, were infected, which is a relatively low incidence. This is largely attributable to nonpharmaceutical preventive interventions, including the behavioral changes of liver-transplant recipients who refrained from venturing out during the COVID-19 pandemic. The infection rate could increase henceforth.

To investigate the protection conferred by neutralizing antibodies against infection, the antibody titer needs frequent measurement to determine the level necessary to prevent infection. However, this is not feasible in clinical practice. As COVID-19 is not a seasonal illness, perennial prevention is essential. Considering the decay rate of neutralizing antibodies, annual booster vaccination seems insufficient to provide preventive immunity. However, with the increased number of individuals with a history of COVID-19 in the community currently, the risk of cluster outbreaks has decreased. Therefore, with regard to vaccination, a multi-societal perspective, which includes infection severity, is needed. As there is an uncertain trend in SARS-CoV-2 infection rates in liver-transplant recipients, continuing booster

我们非常感谢 Daungsupawong 和 Wiwanitkit 博士就我们最近发表的文章《肝移植受者接种基于 mRNA 的严重急性呼吸道综合征冠状病毒 2 疫苗后的抗体滴度》1 所提出的见解。我们报告称,mRNA 疫苗在肝移植受者中诱导的体液反应和获得性抗体衰减率与健康人相似。在日本,由于当地政府免费提供冠状病毒病(COVID-19)疫苗接种,肝移植受者可以获得良好的医疗保健服务。在整个研究期间,成人都有资格接种疫苗,而儿童则可以在中途接种疫苗。根据研究结果,肝移植受者定期接种疫苗,并在研究结束后继续接受加强接种(第二次接种后每 6 个月接种一次)。在研究中,目标患者第二次接种后的平均观察期为 328 ± 64 天。关于接种前的感染史,影响可能很小,因为只有两名受者在第一次测量时检测出抗核苷酸抗体阳性。虽然目前还没有感染率的数据,但在研究完成后的一年内,没有受种者患上重症肺炎。根据日本移植协会(Japan Society for Transplantation)截至 2022 年 8 月 31 日的 COVID-19 病例统计3 ,包括本机构在内,仅有 237 名受者受到感染,发病率相对较低。这主要归功于非药物预防干预措施,包括肝移植受者在 COVID-19 大流行期间避免外出的行为改变。为了研究中和抗体对感染的保护作用,需要经常测量抗体滴度,以确定预防感染所需的水平。然而,这在临床实践中并不可行。由于 COVID-19 并非季节性疾病,因此常年预防至关重要。考虑到中和抗体的衰减率,每年加强接种疫苗似乎不足以提供预防性免疫力。然而,随着目前社区中有过 COVID-19 病史的人数增加,集群爆发的风险已经降低。因此,在疫苗接种方面,需要从包括感染严重程度在内的多社会角度出发。由于肝移植受者的 SARS-CoV-2 感染率呈不确定趋势,继续加强疫苗接种以及疫苗接种时间与发病之间的关联构成了重要的研究领域。COVID-19 是一个严重的全球健康问题,移植受者感染 SARS-CoV-2 的风险尤其高。我们的研究结果表明,针对 SARS-CoV-2 的 mRNA 疫苗对肝移植受者是安全有效的,加强接种有助于维持抗体水平。我们将继续开展肝移植受者SARS-CoV-2感染的预防和治疗研究。YO负责数据收集。YS组织了研究的进行,并对手稿进行了严格审阅。所有作者均已阅读并批准了最终稿件。本研究未从公共、商业或非营利部门的任何资助机构获得任何特定资助:本信的所有评论均符合《赫尔辛基宣言》。原始研究方案已获得信州大学伦理委员会批准(注册号:5265):知情同意书:在将所有参与者和/或其家属纳入研究之前,已获得他们的知情同意书。研究/试验的登记和登记号:不适用:动物研究:动物研究:不详。
{"title":"Author's reply: COVID-19 vaccine in liver transplant recipients","authors":"Atsuyoshi Mita,&nbsp;Yasunari Ohno,&nbsp;Yuji Soejima","doi":"10.1002/ags3.12752","DOIUrl":"https://doi.org/10.1002/ags3.12752","url":null,"abstract":"<p>We gratefully acknowledge Drs. Daungsupawong and Wiwanitkit's insights regarding our recently published article “Antibody titer after administration of mRNA-based vaccine against severe acute respiratory syndrome coronavirus 2 in liver transplant recipients.”<span><sup>1</sup></span> We reported that mRNA vaccines induce similar humoral responses and decay rates of acquired antibodies in liver-transplant recipients as in healthy individuals.<span><sup>2</sup></span> Accordingly, we deduced that liver-transplant recipients should receive booster vaccination. Although we agree with the majority of the authors' points, we would like to address some of their concerns that were expressed in their Letter to the Editor.</p><p>In Japan, as the local government has provided free vaccination against the coronavirus disease (COVID-19), liver-transplant recipients have good access to healthcare. Adults were eligible for vaccination throughout, and children could receive vaccination midway through, the study period. Based on the study's results, liver-transplant recipients received regular vaccinations, and continued to receive booster vaccinations (given every 6 months after the second vaccination) even after the study ended. The average observation period for target patients after the second vaccination was 328 ± 64 days in the study.</p><p>With regard to the pre-vaccination history of infections, the impact was likely small, as only two recipients tested positive for anti-nucleocapsid antibodies at the first measurement. Although, data on current infection rates are unavailable, no recipient has developed severe pneumonia in the 1 year since study completion. In the statistics reported by the Japan Society for Transplantation on COVID-19 cases up to August 31, 2022,<span><sup>3</sup></span> only 237 recipients, including those from our facility, were infected, which is a relatively low incidence. This is largely attributable to nonpharmaceutical preventive interventions, including the behavioral changes of liver-transplant recipients who refrained from venturing out during the COVID-19 pandemic. The infection rate could increase henceforth.</p><p>To investigate the protection conferred by neutralizing antibodies against infection, the antibody titer needs frequent measurement to determine the level necessary to prevent infection. However, this is not feasible in clinical practice. As COVID-19 is not a seasonal illness, perennial prevention is essential. Considering the decay rate of neutralizing antibodies, annual booster vaccination seems insufficient to provide preventive immunity. However, with the increased number of individuals with a history of COVID-19 in the community currently, the risk of cluster outbreaks has decreased. Therefore, with regard to vaccination, a multi-societal perspective, which includes infection severity, is needed. As there is an uncertain trend in SARS-CoV-2 infection rates in liver-transplant recipients, continuing booster","PeriodicalId":8030,"journal":{"name":"Annals of Gastroenterological Surgery","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2023-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ags3.12752","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140043046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of the COVID-19 pandemic on short-term postoperative outcomes for colorectal perforation: A nationwide study in Japan based on the National Clinical Database COVID-19 大流行对结直肠穿孔术后短期疗效的影响:基于国家临床数据库的日本全国性研究
IF 2.7 4区 医学 Q1 Medicine Pub Date : 2023-11-23 DOI: 10.1002/ags3.12758
Shimpei Ogawa, Hideki Endo, Masahiro Yoshida, Tomomitsu Tsuru, Michio Itabashi, Hiroyuki Yamamoto, Yoshihiro Kakeji, Hideki Ueno, Yuko Kitagawa, Taizo Hibi, Akinobu Taketomi, Norihiko Ikeda, Masaki Mori

Aim

Possible negative effects of the COVID-19 pandemic on short-term postoperative outcomes for colorectal perforation in Japan were examined in this study.

Methods

The National Clinical Database (NCD) is a large-scale database including more than 95% of surgical cases in Japan. We analyzed 13 107 cases of colorectal perforation from 2019 to 2021. National data were analyzed, and subgroup analyses were conducted for subjects in prefectures with high infection levels (HILs) and metropolitan areas (Tokyo Met. and Osaka Pref.). Postoperative 30-day mortality, surgical mortality, and postoperative complications (Clavien–Dindo grade ≥3) were examined. Months were considered to have significantly high or low mortality or complication rates, if the 95% confidence interval (CI) of the standardized mortality (morbidity) ratio (SMR) does not contain 1.

Results

In the NCD, postoperative 30-day mortality occurred in 1371 subjects (10.5%), surgical mortality in 1805 (13.8%), and postoperative complications in 3950 (30.1%). Significantly higher SMRs were found for 30-day mortality in November 2020 (14.6%, 1.39 [95% CI: 1.04–1.83]) and February 2021 (14.6%, 1.48 [95% CI: 1.10–1.96]), and for postoperative complications in June 2020 (37.3%, 1.28 [95% CI: 1.08–1.52]) and November 2020 (36.4%, 1.21 [95% CI: 1.01–1.44]). The SMRs for surgical mortality were not significantly high in any month. In prefectures with HILs and large metropolitan areas, there were few months with significantly higher SMRs.

Conclusions

The COVID-19 pandemic had limited negative effects on postoperative outcomes in patients with colorectal perforation. These findings suggest that the emergency system for colorectal perforation in Japan was generally maintained during the pandemic.

本研究探讨了COVID-19大流行对日本结直肠穿孔术后短期疗效可能产生的负面影响。日本国家临床数据库(NCD)是一个大型数据库,收录了日本95%以上的手术病例。我们分析了 2019 年至 2021 年的 13 107 例结直肠穿孔病例。我们对全国数据进行了分析,并对高感染县(HILs)和大都市地区(东京都和大阪府)的受试者进行了亚组分析。对术后 30 天死亡率、手术死亡率和术后并发症(Clavien-Dindo 分级≥3)进行了研究。如果标准化死亡率(发病率)比值(SMR)的 95% 置信区间(CI)不包含 1,则认为各月的死亡率或并发症发生率明显偏高或偏低。在 NCD 中,术后 30 天死亡率为 1371 例(10.5%),手术死亡率为 1805 例(13.8%),术后并发症为 3950 例(30.1%)。2020 年 11 月(14.6%,1.39 [95% CI:1.04-1.83])和 2021 年 2 月(14.6%,1.48 [95% CI:1.10-1.96])的 30 天死亡率的 SMRs 明显更高,2020 年 6 月(37.3%,1.28 [95% CI:1.08-1.52])和 2020 年 11 月(36.4%,1.21 [95% CI:1.01-1.44])的术后并发症的 SMRs 明显更高。任何月份的手术死亡率的SMRs都没有明显偏高。COVID-19大流行对结直肠穿孔患者术后结果的负面影响有限。这些研究结果表明,大流行期间日本的结直肠穿孔急救系统总体上得以维持。
{"title":"Effects of the COVID-19 pandemic on short-term postoperative outcomes for colorectal perforation: A nationwide study in Japan based on the National Clinical Database","authors":"Shimpei Ogawa,&nbsp;Hideki Endo,&nbsp;Masahiro Yoshida,&nbsp;Tomomitsu Tsuru,&nbsp;Michio Itabashi,&nbsp;Hiroyuki Yamamoto,&nbsp;Yoshihiro Kakeji,&nbsp;Hideki Ueno,&nbsp;Yuko Kitagawa,&nbsp;Taizo Hibi,&nbsp;Akinobu Taketomi,&nbsp;Norihiko Ikeda,&nbsp;Masaki Mori","doi":"10.1002/ags3.12758","DOIUrl":"10.1002/ags3.12758","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>Possible negative effects of the COVID-19 pandemic on short-term postoperative outcomes for colorectal perforation in Japan were examined in this study.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>The National Clinical Database (NCD) is a large-scale database including more than 95% of surgical cases in Japan. We analyzed 13 107 cases of colorectal perforation from 2019 to 2021. National data were analyzed, and subgroup analyses were conducted for subjects in prefectures with high infection levels (HILs) and metropolitan areas (Tokyo Met. and Osaka Pref.). Postoperative 30-day mortality, surgical mortality, and postoperative complications (Clavien–Dindo grade ≥3) were examined. Months were considered to have significantly high or low mortality or complication rates, if the 95% confidence interval (CI) of the standardized mortality (morbidity) ratio (SMR) does not contain 1.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>In the NCD, postoperative 30-day mortality occurred in 1371 subjects (10.5%), surgical mortality in 1805 (13.8%), and postoperative complications in 3950 (30.1%). Significantly higher SMRs were found for 30-day mortality in November 2020 (14.6%, 1.39 [95% CI: 1.04–1.83]) and February 2021 (14.6%, 1.48 [95% CI: 1.10–1.96]), and for postoperative complications in June 2020 (37.3%, 1.28 [95% CI: 1.08–1.52]) and November 2020 (36.4%, 1.21 [95% CI: 1.01–1.44]). The SMRs for surgical mortality were not significantly high in any month. In prefectures with HILs and large metropolitan areas, there were few months with significantly higher SMRs.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>The COVID-19 pandemic had limited negative effects on postoperative outcomes in patients with colorectal perforation. These findings suggest that the emergency system for colorectal perforation in Japan was generally maintained during the pandemic.</p>\u0000 </section>\u0000 </div>","PeriodicalId":8030,"journal":{"name":"Annals of Gastroenterological Surgery","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2023-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ags3.12758","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139244136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Key nodal stations for predicting splenic hilar nodal metastasis in upper advanced gastric cancer without invasion of the greater curvature 预测未侵犯大弯的上部晚期胃癌脾门结节转移的关键结节站
IF 2.7 4区 医学 Q1 Medicine Pub Date : 2023-11-22 DOI: 10.1002/ags3.12759
Masashi Nishino, Takaki Yoshikawa, Masahiro Yura, Rei Ogawa, Ryota Sakon, Kenichi Ishizu, Takeyuki Wada, Tsutomu Hayashi, Yukinori Yamagata

Background

Standard surgery for upper advanced gastric cancer without invasion of the greater curvature (UGC-GC) is spleen-preserving D2 total gastrectomy without dissection of the splenic-hilar nodes (#10). However, some patients with nodal metastasis to #10 survive more than 5 years due to nodal dissection of #10. If nodal metastasis to #10 is predictable based on the positivity of other nodes dissected by the current standard surgery without #10 nodal dissection, physicians may be able to consider #10 dissection.

Methods

This study retrospectively reviewed data from the National Cancer Center Hospital in Japan between 2000 and 2012. We selected cases that met the following criteria: (1) D2 or more total gastrectomy with splenectomy, (2) UGC-GC, and (3) histological type is gastric adenocarcinoma. We performed univariate and multivariate analyses concerning lymph node stations associated with #10 metastasis.

Results

A total of 366 patients were examined. A multivariate analysis revealed that #10 metastasis was associated with positivity of the nodes along the short gastric arteries (#4sa) and distal nodes along the splenic artery (#11d) (#4sa: p = 0.003, #11d: p = 0.016). When either key node was positive, the metastatic rate of #10 was 24.4%, and the therapeutic value index was 13.3.

Conclusions

#4sa and #11d were key lymph nodes predicting #10 nodal metastasis in UGC-GC. When these key nodes are positive on computed tomography before surgery or according to a rapid pathological examination during surgery, dissection of #10 should be considered even if upper advanced tumors are not invading the greater curvature.

无大弯侵犯的上部晚期胃癌(UGC-GC)的标准手术是保脾 D2 全胃切除术,不切除脾-肝结节(#10)。但是,一些 10 号结节转移的患者会因为 10 号结节切除而存活 5 年以上。本研究回顾性审查了日本国立癌症中心医院在 2000 年至 2012 年期间的数据。我们选择了符合以下标准的病例:(1)D2或以上全胃切除术加脾切除;(2)UGC-GC;(3)组织学类型为胃腺癌。我们对与 10 号转移相关的淋巴结站进行了单变量和多变量分析。多变量分析显示,10号转移与沿胃短动脉的淋巴结(4号sa)和沿脾动脉的远端淋巴结(11号d)阳性有关(4号sa:p = 0.003,11号d:p = 0.016)。4sa和11d是预测UGC-GC中10号结节转移的关键淋巴结。当术前计算机断层扫描或术中快速病理检查显示这些关键结节阳性时,即使上部晚期肿瘤未侵犯大弯,也应考虑切除10号结节。
{"title":"Key nodal stations for predicting splenic hilar nodal metastasis in upper advanced gastric cancer without invasion of the greater curvature","authors":"Masashi Nishino,&nbsp;Takaki Yoshikawa,&nbsp;Masahiro Yura,&nbsp;Rei Ogawa,&nbsp;Ryota Sakon,&nbsp;Kenichi Ishizu,&nbsp;Takeyuki Wada,&nbsp;Tsutomu Hayashi,&nbsp;Yukinori Yamagata","doi":"10.1002/ags3.12759","DOIUrl":"10.1002/ags3.12759","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Standard surgery for upper advanced gastric cancer without invasion of the greater curvature (UGC-GC) is spleen-preserving D2 total gastrectomy without dissection of the splenic-hilar nodes (#10). However, some patients with nodal metastasis to #10 survive more than 5 years due to nodal dissection of #10. If nodal metastasis to #10 is predictable based on the positivity of other nodes dissected by the current standard surgery without #10 nodal dissection, physicians may be able to consider #10 dissection.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This study retrospectively reviewed data from the National Cancer Center Hospital in Japan between 2000 and 2012. We selected cases that met the following criteria: (1) D2 or more total gastrectomy with splenectomy, (2) UGC-GC, and (3) histological type is gastric adenocarcinoma. We performed univariate and multivariate analyses concerning lymph node stations associated with #10 metastasis.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>A total of 366 patients were examined. A multivariate analysis revealed that #10 metastasis was associated with positivity of the nodes along the short gastric arteries (#4sa) and distal nodes along the splenic artery (#11d) (#4sa: <i>p</i> = 0.003, #11d: <i>p</i> = 0.016). When either key node was positive, the metastatic rate of #10 was 24.4%, and the therapeutic value index was 13.3.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>#4sa and #11d were key lymph nodes predicting #10 nodal metastasis in UGC-GC. When these key nodes are positive on computed tomography before surgery or according to a rapid pathological examination during surgery, dissection of #10 should be considered even if upper advanced tumors are not invading the greater curvature.</p>\u0000 </section>\u0000 </div>","PeriodicalId":8030,"journal":{"name":"Annals of Gastroenterological Surgery","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2023-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ags3.12759","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139246552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tele-proctoring for minimally invasive surgery across Japan: An initial step toward a new approach to improving the disparity of surgical care and supporting surgical education 日本全国微创手术远程监查:迈向改善外科护理差异和支持外科教育新方法的第一步
IF 2.7 4区 医学 Q1 Medicine Pub Date : 2023-11-21 DOI: 10.1002/ags3.12750
Ichiro Takemasa, Koichi Okuya, Kenji Okita, Emi Akizuki, Masaaki Miyo, Masayuki Ishii, Ryo Miura, Momoko Ichihara, Korai Takahiro, Eiji Oki, Mitsuhisa Takatsuki, Susumu Eguchi, Daisuke Ichikawa, Yuko Kitagawa, Yoshiharu Sakai, Masaki Mori

Aim

The aim of this study was to verify the clinical feasibility of tele-proctoring using our ultra-low latency communication system with shared internet access.

Methods

Connections between two multiple remote locations at various distances were established through the TELEPRO® tele-proctoring system. The server records the latency between the two locations for tele-proctoring using the annotations. Questionnaires were administered to the surgeons, assistants, and medical staff. Respondents rated the quickness and quality of communication in terms of latency and disturbances in the audio, video, and usefulness of the live telestrations with annotation.

Results

Seven hospitals tele-proctored with Sapporo Medical University between January 2021 and September 2022. The median latency of annotation between the two locations ranged from 24.5 to 48.5 ms. No major technological problems occurred, such as streaming interruption, loss of video or audio, poor resolution. The video encoding time was 10 ms, and its decoding time was 0.8 ms. The total latency positively correlated with the distance between two locations (R = 0.55, p < 0.01). The quality of communication regarding latency, disturbance, and surgical education with intraoperative annotative instructions showed similar trends, with perfectly fine being the most common response. No significant differences in surgical quality, educational effect, or social impact were observed between the latency ≥30 and <30 ms groups for whether the size of latency affects surgical education.

Conclusion

The feasibility of the tele-proctoring system is expected to be a sustainable approach to help education for young surgeons and surgical supports in rural areas, thereby reducing disparities in health care.

本研究的目的是验证使用我们的超低延迟通信系统和共享互联网接入进行远程监考的临床可行性。服务器利用注释记录两个远程监考地点之间的延迟。对外科医生、助手和医务人员进行了问卷调查。2021 年 1 月至 2022 年 9 月期间,七家医院与札幌医科大学进行了远程监考。两地之间注释的中位延迟时间为 24.5 至 48.5 毫秒。没有出现流媒体中断、视频或音频丢失、分辨率低等重大技术问题。视频编码时间为 10 毫秒,解码时间为 0.8 毫秒。总延迟时间与两地之间的距离呈正相关(R = 0.55,p < 0.01)。关于延迟、干扰和术中注释说明的手术教育的交流质量显示出相似的趋势,最常见的回答是完全好。就延迟时间的长短是否会影响手术教育而言,延迟时间≥30 毫秒组和<30 毫秒组在手术质量、教育效果或社会影响方面均未发现明显差异。远程监查系统的可行性有望成为帮助农村地区年轻外科医生和手术支持人员接受教育的一种可持续方法,从而缩小医疗保健方面的差距。
{"title":"Tele-proctoring for minimally invasive surgery across Japan: An initial step toward a new approach to improving the disparity of surgical care and supporting surgical education","authors":"Ichiro Takemasa,&nbsp;Koichi Okuya,&nbsp;Kenji Okita,&nbsp;Emi Akizuki,&nbsp;Masaaki Miyo,&nbsp;Masayuki Ishii,&nbsp;Ryo Miura,&nbsp;Momoko Ichihara,&nbsp;Korai Takahiro,&nbsp;Eiji Oki,&nbsp;Mitsuhisa Takatsuki,&nbsp;Susumu Eguchi,&nbsp;Daisuke Ichikawa,&nbsp;Yuko Kitagawa,&nbsp;Yoshiharu Sakai,&nbsp;Masaki Mori","doi":"10.1002/ags3.12750","DOIUrl":"10.1002/ags3.12750","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>The aim of this study was to verify the clinical feasibility of tele-proctoring using our ultra-low latency communication system with shared internet access.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Connections between two multiple remote locations at various distances were established through the TELEPRO® tele-proctoring system. The server records the latency between the two locations for tele-proctoring using the annotations. Questionnaires were administered to the surgeons, assistants, and medical staff. Respondents rated the quickness and quality of communication in terms of latency and disturbances in the audio, video, and usefulness of the live telestrations with annotation.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Seven hospitals tele-proctored with Sapporo Medical University between January 2021 and September 2022. The median latency of annotation between the two locations ranged from 24.5 to 48.5 ms. No major technological problems occurred, such as streaming interruption, loss of video or audio, poor resolution. The video encoding time was 10 ms, and its decoding time was 0.8 ms. The total latency positively correlated with the distance between two locations (<i>R</i> = 0.55, <i>p</i> &lt; 0.01). The quality of communication regarding latency, disturbance, and surgical education with intraoperative annotative instructions showed similar trends, with perfectly fine being the most common response. No significant differences in surgical quality, educational effect, or social impact were observed between the latency ≥30 and &lt;30 ms groups for whether the size of latency affects surgical education.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>The feasibility of the tele-proctoring system is expected to be a sustainable approach to help education for young surgeons and surgical supports in rural areas, thereby reducing disparities in health care.</p>\u0000 </section>\u0000 </div>","PeriodicalId":8030,"journal":{"name":"Annals of Gastroenterological Surgery","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2023-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ags3.12750","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139253415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Blood flow ratio in the gastric conduit measured by laser Doppler flowmetry: A predictor of anastomotic leakage after esophagectomy 通过激光多普勒血流测量仪测量胃导管中的血流比率:食管切除术后吻合口漏的预测指标
IF 2.7 4区 医学 Q1 Medicine Pub Date : 2023-11-20 DOI: 10.1002/ags3.12754
Hirotaka Ishida, Toshiaki Fukutomi, Yusuke Taniyama, Chiaki Sato, Hiroshi Okamoto, Yohei Ozawa, Yu Onodera, Ken Koseki, Michiaki Unno, Takashi Kamei

Background

Anastomotic leakage after esophagectomy is a common complication. Laser Doppler flowmetry (LDF) can quantitatively evaluate the blood flow in the gastric conduit.

Methods

A total of 326 patients who underwent thoracoscopic/robot-assisted esophagectomy followed by gastric conduit reconstruction and end-to-side anastomosis were enrolled. We divided the gastric conduit into zones I (dominated by the right gastroepiploic vessels), II (dominated by the left gastroepiploic vessels), and III (perfused with short gastric vessels). Before pulling up the gastric conduit to the neck, LDF values were measured at the pylorus, the border between zones I and II (zone I/II), the border between zones II and III (zone II/III), and the gastric conduit tip (tip). The blood flow ratio was calculated as the LDF value divided by the LDF value at the pylorus.

Results

Anastomotic leakage developed in 32 of 326 patients. Leakage was significantly associated with the blood flow ratio at the tip (p < 0.001), but not at zone I/II, zone II/III, and the anastomotic site. The receiver-operating characteristic curve analysis identified an anastomotic leakage cutoff ratio of 0.41 (at the tip). A multivariate Cox analysis showed that a blood flow ratio <0.41 at the tip was an independent risk factor for anastomotic leakage (p < 0.001).

Conclusion

Anastomotic leakage after esophagectomy was significantly associated with the blood flow ratio at the tip of the gastric conduit. Preservation of the blood supply to the tip via the gastric wall might contribute to a decreased incidence of anastomotic leakage.

食管切除术后吻合口漏是一种常见的并发症。激光多普勒血流测量仪(LDF)可定量评估胃导管内的血流情况。我们共登记了326例接受胸腔镜/机器人辅助食管切除术后进行胃导管重建和端侧吻合术的患者。我们将胃导管分为 I 区(以右胃息肉血管为主)、II 区(以左胃息肉血管为主)和 III 区(以短胃血管灌注)。在将胃导管拉至颈部之前,在幽门、I 区和 II 区交界处(I/II 区)、II 区和 III 区交界处(II/III 区)以及胃导管顶端(顶端)测量 LDF 值。血流比率的计算方法是 LDF 值除以幽门处的 LDF 值。326 例患者中有 32 例出现吻合口渗漏。渗漏与顶端的血流比率有明显关系(p < 0.001),但与 I/II 区、II/III 区和吻合口部位无关。接受者操作特征曲线分析确定吻合口渗漏临界比率为 0.41(顶端)。多变量考克斯分析显示,顶端血流比小于 0.41 是吻合口漏的独立风险因素(p < 0.001)。食管切除术后吻合口漏与胃导管顶端血流比显著相关。食管切除术后吻合口漏与胃导管顶端的血流比率明显相关。通过胃壁保留对顶端的血液供应可能有助于降低吻合口漏的发生率。
{"title":"Blood flow ratio in the gastric conduit measured by laser Doppler flowmetry: A predictor of anastomotic leakage after esophagectomy","authors":"Hirotaka Ishida,&nbsp;Toshiaki Fukutomi,&nbsp;Yusuke Taniyama,&nbsp;Chiaki Sato,&nbsp;Hiroshi Okamoto,&nbsp;Yohei Ozawa,&nbsp;Yu Onodera,&nbsp;Ken Koseki,&nbsp;Michiaki Unno,&nbsp;Takashi Kamei","doi":"10.1002/ags3.12754","DOIUrl":"10.1002/ags3.12754","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Anastomotic leakage after esophagectomy is a common complication. Laser Doppler flowmetry (LDF) can quantitatively evaluate the blood flow in the gastric conduit.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A total of 326 patients who underwent thoracoscopic/robot-assisted esophagectomy followed by gastric conduit reconstruction and end-to-side anastomosis were enrolled. We divided the gastric conduit into zones I (dominated by the right gastroepiploic vessels), II (dominated by the left gastroepiploic vessels), and III (perfused with short gastric vessels). Before pulling up the gastric conduit to the neck, LDF values were measured at the pylorus, the border between zones I and II (zone I/II), the border between zones II and III (zone II/III), and the gastric conduit tip (tip). The blood flow ratio was calculated as the LDF value divided by the LDF value at the pylorus.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Anastomotic leakage developed in 32 of 326 patients. Leakage was significantly associated with the blood flow ratio at the tip (<i>p</i> &lt; 0.001), but not at zone I/II, zone II/III, and the anastomotic site. The receiver-operating characteristic curve analysis identified an anastomotic leakage cutoff ratio of 0.41 (at the tip). A multivariate Cox analysis showed that a blood flow ratio &lt;0.41 at the tip was an independent risk factor for anastomotic leakage (<i>p</i> &lt; 0.001).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Anastomotic leakage after esophagectomy was significantly associated with the blood flow ratio at the tip of the gastric conduit. Preservation of the blood supply to the tip via the gastric wall might contribute to a decreased incidence of anastomotic leakage.</p>\u0000 </section>\u0000 </div>","PeriodicalId":8030,"journal":{"name":"Annals of Gastroenterological Surgery","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2023-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ags3.12754","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139255150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Serum NY-ESO-1 and p53 antibodies as useful tumor markers in gastric cancer 血清 NY-ESO-1 和 p53 抗体是胃癌的有用肿瘤标志物
IF 2.7 4区 医学 Q1 Medicine Pub Date : 2023-11-20 DOI: 10.1002/ags3.12757
Junji Kawada, Takuro Saito, Yukinori Kurokawa, Ryohei Kawabata, Atsushi Takeno, Tomohira Takeoka, Yohei Nose, Hisashi Wada, Hidetoshi Eguchi, Yuichiro Doki, Osaka University Clinical Research Group for Gastroenterological Study

Purpose

The NY-ESO-1 antigen is highly immunogenic and often spontaneously induces an immune response in patients with cancer. We conducted a large-scale multicenter cohort study to investigate the utility of serum NY-ESO-1 and p53 antibodies as predictive markers for the postoperative recurrence of gastric cancer. Here, we examined the usefulness of pre-treatment NY-ESO-1 and p53 antibodies as tumor markers for the diagnosis of gastric cancer in combination with carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9).

Methods

A total of 1031 patients with cT3-4 gastric cancer were enrolled in the study. NY-ESO-1 and p53 antibodies were assessed prior to treatment. The positivity of NY-ESO-1 and p53 antibodies, CEA, and CA19-9 was evaluated before treatment.

Results

Serum NY-ESO-1 and p53 antibodies were positive in 12.6% and 18.1% of the patients, respectively. Positive NY-ESO-1 antibody response was correlated with male gender, higher cStage, and upper tumor location. However, a positive p53 antibody response was not associated with tumor factors. The combination of NY-ESO-1 or p53 antibody response with CEA and CA19-9, or the 4-factors, was positive in 45.1%, 49.6%, and 53.8% of patients, respectively. Moreover, the 4-factor combination was able to detect >60% of cStage III-IV diseases, which was 14% higher than that with the combination of CEA and CA19-9.

Conclusion

The combination of NY-ESO-1 and p53 antibody responses to CEA and CA19-9 increases the diagnostic accuracy of gastric cancer. Serum NY-ESO-1 and p53 antibodies may be useful tumor markers for gastric cancer.

NY-ESO-1 抗原具有高度免疫原性,通常会自发诱导癌症患者产生免疫反应。我们开展了一项大规模多中心队列研究,以调查血清NY-ESO-1和p53抗体作为胃癌术后复发预测标志物的效用。在此,我们研究了治疗前NY-ESO-1和p53抗体作为肿瘤标志物与癌胚抗原(CEA)和碳水化合物抗原19-9(CA19-9)结合诊断胃癌的实用性。研究共纳入了 1031 名 cT3-4 期胃癌患者,在治疗前评估了 NY-ESO-1 和 p53 抗体。治疗前评估了NY-ESO-1和p53抗体、CEA和CA19-9的阳性率。12.6%和18.1%的患者血清NY-ESO-1和p53抗体呈阳性。NY-ESO-1抗体阳性反应与男性性别、较高的c分期和肿瘤位置偏上有关。然而,p53 抗体阳性反应与肿瘤因素无关。45.1%、49.6% 和 53.8%的患者的 NY-ESO-1 或 p53 抗体反应与 CEA 和 CA19-9 或 4 因子相结合呈阳性。此外,4因子组合能检测出60%以上的cStage III-IV疾病,比CEA和CA19-9组合高出14%。血清NY-ESO-1和p53抗体可能是胃癌的有用肿瘤标志物。
{"title":"Serum NY-ESO-1 and p53 antibodies as useful tumor markers in gastric cancer","authors":"Junji Kawada,&nbsp;Takuro Saito,&nbsp;Yukinori Kurokawa,&nbsp;Ryohei Kawabata,&nbsp;Atsushi Takeno,&nbsp;Tomohira Takeoka,&nbsp;Yohei Nose,&nbsp;Hisashi Wada,&nbsp;Hidetoshi Eguchi,&nbsp;Yuichiro Doki,&nbsp;Osaka University Clinical Research Group for Gastroenterological Study","doi":"10.1002/ags3.12757","DOIUrl":"10.1002/ags3.12757","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Purpose</h3>\u0000 \u0000 <p>The NY-ESO-1 antigen is highly immunogenic and often spontaneously induces an immune response in patients with cancer. We conducted a large-scale multicenter cohort study to investigate the utility of serum NY-ESO-1 and p53 antibodies as predictive markers for the postoperative recurrence of gastric cancer. Here, we examined the usefulness of pre-treatment NY-ESO-1 and p53 antibodies as tumor markers for the diagnosis of gastric cancer in combination with carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A total of 1031 patients with cT3-4 gastric cancer were enrolled in the study. NY-ESO-1 and p53 antibodies were assessed prior to treatment. The positivity of NY-ESO-1 and p53 antibodies, CEA, and CA19-9 was evaluated before treatment.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Serum NY-ESO-1 and p53 antibodies were positive in 12.6% and 18.1% of the patients, respectively. Positive NY-ESO-1 antibody response was correlated with male gender, higher cStage, and upper tumor location. However, a positive p53 antibody response was not associated with tumor factors. The combination of NY-ESO-1 or p53 antibody response with CEA and CA19-9, or the 4-factors, was positive in 45.1%, 49.6%, and 53.8% of patients, respectively. Moreover, the 4-factor combination was able to detect &gt;60% of cStage III-IV diseases, which was 14% higher than that with the combination of CEA and CA19-9.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>The combination of NY-ESO-1 and p53 antibody responses to CEA and CA19-9 increases the diagnostic accuracy of gastric cancer. Serum NY-ESO-1 and p53 antibodies may be useful tumor markers for gastric cancer.</p>\u0000 </section>\u0000 </div>","PeriodicalId":8030,"journal":{"name":"Annals of Gastroenterological Surgery","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2023-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ags3.12757","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139257967","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of thoracic shape on the surgical outcomes of laparoscopic-assisted living donor hepatectomy 胸廓形状对腹腔镜辅助活体肝切除术手术效果的影响
IF 2.7 4区 医学 Q1 Medicine Pub Date : 2023-11-17 DOI: 10.1002/ags3.12755
Kosuke Tanaka, Satoshi Ogiso, Tomoaki Yoh, Ahmed Hussein Abdelhafez, Yuki Masano, Shinya Okumura, Shoichi Kageyama, Takashi Ito, Koichiro Hata, Etsuro Hatano

Background

Although laparoscopic-assisted donor hepatectomy (LADH) has become the definitive procedure for harvesting living donor livers, its surgical outcomes in association with donor body shape have not been elucidated.

Methods

The impact of donor factors, including thoracic shape, on LADH outcomes was retrospectively investigated. Thoracic anthropometric data were examined in all LADHs with a left/right graft between 2013 and 2022.

Results

The study included 210 LADHs, consisting of 106 left- and 104 right-lobe donors with similar blood loss and similar operation time. Males have greater thoracic depth and greater thoracic width compared with females, respectively. Thoracic depth was associated with graft weight (p < 0.001), blood loss (p < 0.001), and operation time (p < 0.001). On multivariate analyses, blood loss >500 mL and operation time >8 h were associated with graft weight in the left-lobe donors, and blood loss >500 mL was associated with thoracic depth in the right-lobe donors.

Conclusion

The greater thoracic depth is associated with massive blood loss in right-lobe donors. Anthropometric parameters might be helpful for estimating LADH outcomes.

虽然腹腔镜辅助供体肝切除术(LADH)已成为获取活体供体肝脏的权威手术,但其手术效果与供体体形的关系尚未阐明。研究人员回顾性地调查了供体因素(包括胸廓形状)对LADH手术效果的影响。研究纳入了210例LADH,包括106例左叶和104例右叶供体,失血量和手术时间相似。与女性相比,男性的胸廓深度更大,胸廓宽度更大。左叶供体的胸廓深度与移植物重量(p 500 mL)相关,手术时间大于 8 小时与移植物重量相关,右叶供体的失血量大于 500 mL 与胸廓深度相关。人体测量参数可能有助于估计 LADH 的结果。
{"title":"Impact of thoracic shape on the surgical outcomes of laparoscopic-assisted living donor hepatectomy","authors":"Kosuke Tanaka,&nbsp;Satoshi Ogiso,&nbsp;Tomoaki Yoh,&nbsp;Ahmed Hussein Abdelhafez,&nbsp;Yuki Masano,&nbsp;Shinya Okumura,&nbsp;Shoichi Kageyama,&nbsp;Takashi Ito,&nbsp;Koichiro Hata,&nbsp;Etsuro Hatano","doi":"10.1002/ags3.12755","DOIUrl":"10.1002/ags3.12755","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Although laparoscopic-assisted donor hepatectomy (LADH) has become the definitive procedure for harvesting living donor livers, its surgical outcomes in association with donor body shape have not been elucidated.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>The impact of donor factors, including thoracic shape, on LADH outcomes was retrospectively investigated. Thoracic anthropometric data were examined in all LADHs with a left/right graft between 2013 and 2022.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The study included 210 LADHs, consisting of 106 left- and 104 right-lobe donors with similar blood loss and similar operation time. Males have greater thoracic depth and greater thoracic width compared with females, respectively. Thoracic depth was associated with graft weight (<i>p</i> &lt; 0.001), blood loss (<i>p</i> &lt; 0.001), and operation time (<i>p</i> &lt; 0.001). On multivariate analyses, blood loss &gt;500 mL and operation time &gt;8 h were associated with graft weight in the left-lobe donors, and blood loss &gt;500 mL was associated with thoracic depth in the right-lobe donors.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>The greater thoracic depth is associated with massive blood loss in right-lobe donors. Anthropometric parameters might be helpful for estimating LADH outcomes.</p>\u0000 </section>\u0000 </div>","PeriodicalId":8030,"journal":{"name":"Annals of Gastroenterological Surgery","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2023-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ags3.12755","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139262467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annals of Gastroenterological Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1